Skip to content

CDR

Ex-defense secretary Gates to speak at NACDS meeting

Former Secretary of Defense Robert Gates will deliver the keynote address at the National Association of Chain Drug Stores Annual Meeting, which is to be held April 20 to April 23 in Palm Beach, Fla. “We are honored to have Dr. Gates as our keynote speaker,” said NACDS president and chief executive

CVS, Walgreens set new standard in Rx

Much has been made of the competition between CVS and Walgreens for supremacy in chain drug retailing and leadership in the health care community. And indeed there is little doubt that these two health care retailers are in a class by themselves when it comes to providing patient care.

Kardashian beauty line to boost CVS store presence

CVS/pharmacy is expanding the Khroma Beauty by Kourtney, Kim and Khloe Kardashian beauty care line to 2,100 stores after a successful initial launch of a limited-edition holiday collection. Beauty licensing company Boldface Group Inc.

Rite Aid hires government affairs executive

Yong Choe has joined Rite Aid Corp. as vice president of federal affairs and public policy. The drug chain said Thursday that Choe will oversee development and execution of policy and strategy relating to federal and state health care issues.

Consumers don’t feel need to get flu shot, poll finds

Despite the recommendation of the Centers for Disease Control and Prevention (CDC), many Americans aren’t convinced that a flu shot is the best way to avoid getting influenza, according to an Ipsos survey. The market research firm said Friday that just 56% of 1,096 U.S.

Walgreens moves up Magnacca

Joseph Magnacca has been promoted to executive vice president at Walgreen Co. Walgreens said Friday that Magnacca, who previously was senior vice president, also retains his title as president of daily living products and solutions.

DOJ files suit against merger of brewers

The U.S. Department of Justice (DOJ) has filed a civil antitrust lawsuit to block Anheuser-Busch InBev’s $20.1 billion deal to acquire total ownership of Grupo Modelo. The DOJ said Thursday that the acquisition would "substantially lessen" competition in the U.S.